BackCalidi Biotherapeutics Overview
Calidi Biotherapeutics Inc - Ordinary Shares - Class A

Calidi Biotherapeutics Target Price

Analysts' 12-month price predictions for CLDI.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.15

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2024-03-21H.C. WainwrightRobert Burns$21202.1% upsideOpen
2023-10-09Robert W. BairdJoel Beatty$95759.4% upsideOpen